Jose T Zaglul MD

Psychiatry•Bradenton, FL

Child & Adolescent Psychiatry, Psychopharmacology

Psychiatry Residency Program Director, Centerstone, Florida

Join to View Full Profile

379 6th Avenue WestBradenton, FL 34205
Phone+1 941-782-4100
Fax+1 941-782-4103

Summary

Dr. Jose Zaglul is a psychiatrist based in Bradenton, FL, with a focus on child and adolescent psychiatry and psychopharmacology. He completed his fellowship in child and adolescent psychiatry and residency in psychiatry at the University of South Florida Morsani, following his medical degree from Universidad Autonoma de Santo Domingo. His work has been published in journals such as Academic Psychiatry and J Fla Med Assoc. Dr. Zaglul has also been involved in various clinical trials, including studies on treatment efficacy for major depressive disorder, schizophrenia, and pediatric conditions such as autism.

Education & Training

University of South Florida MorsaniFellowship, Child and Adolescent Psychiatry, 1993 - 1995
University of South Florida MorsaniResidency, Psychiatry, 1989 - 1993
Universidad Autonoma de Santo DomingoClass of 1986

Certifications & Licensure

FL State Medical License 1991 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01
Completed
Phase 3
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD Start of enrollment: 2016 Jan 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Rethinking Psychiatry Residency Training as Community Program Directors.
Rebecca S Lundquist, Omair Abbasi, Narpinder Kaur Malhi, Salma Malik, Maria P Chona San Gabriel
Academic Psychiatry. 2024-10-01